Perspectives dans le traitement du diabète de type 2. Place de l'insulinotherapie ?
- Other title
- Perspectives in the treatment of type 2 diabetes. Place of insulin therapy ? (en)
- Author
- BRINGER, J; RENARD, E; GALTIER DEREURE, F; JAFFIOL, C
Hôp. Lapeyronie, serv. endocrinologie, 34000 Montpellier, France - Conference title
- Thérapeutiques futures du diabète. Symposium
- Conference name
- The future of diabetes therapy. SymposiumThérapeutiques futures du diabète. Symposium (Paris 1994-01-27)
- Author (monograph)
- Lilly France, Saint-Cloud, France (Funder/Sponsor)
- Source
Diabète et métabolisme (Paris). = Diabetes & metabolism. 1994, Vol 20, Num 2BIS, pp 211-218 ; ref : 49 ref
- ISSN
- 0338-1684
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- Masson, Paris
- Publication country
- France
- Document type
- Conference Paper
- Language
- French
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01C Management. Various non-drug treatments. Langerhans islet grafts
- Discipline
- Endocrinopathies
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 4267887
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Diab\u00e8te et m\u00e9tabolisme (Paris)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Diab\u00e8te m\u00e9tab. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:4:\"2BIS\";s:8:\"\u0000*\u0000spage\";s:3:\"211\";s:8:\"\u0000*\u0000epage\";s:3:\"218\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0338-1684\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BRINGER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"RENARD, E\";i:1;s:18:\"GALTIER DEREURE, F\";i:2;s:10:\"JAFFIOL, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"Th\u00e9rapeutiques futures du diab\u00e8te. Symposium\";s:8:\"\u0000*\u0000title\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:6:\"Masson\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Diab\u00e8te et m\u00e9tabolisme (Paris)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Diab\u00e8te m\u00e9tab. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:4:\"2BIS\";s:8:\"\u0000*\u0000spage\";s:3:\"211\";s:8:\"\u0000*\u0000epage\";s:3:\"218\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0338-1684\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BRINGER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"RENARD, E\";i:1;s:18:\"GALTIER DEREURE, F\";i:2;s:10:\"JAFFIOL, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"Th\u00e9rapeutiques futures du diab\u00e8te. Symposium\";s:8:\"\u0000*\u0000title\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:6:\"Masson\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Diab\u00e8te et m\u00e9tabolisme (Paris)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Diab\u00e8te m\u00e9tab. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:4:\"2BIS\";s:8:\"\u0000*\u0000spage\";s:3:\"211\";s:8:\"\u0000*\u0000epage\";s:3:\"218\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0338-1684\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BRINGER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"RENARD, E\";i:1;s:18:\"GALTIER DEREURE, F\";i:2;s:10:\"JAFFIOL, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"Th\u00e9rapeutiques futures du diab\u00e8te. Symposium\";s:8:\"\u0000*\u0000title\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:6:\"Masson\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Diab\u00e8te et m\u00e9tabolisme (Paris)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Diab\u00e8te m\u00e9tab. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:4:\"2BIS\";s:8:\"\u0000*\u0000spage\";s:3:\"211\";s:8:\"\u0000*\u0000epage\";s:3:\"218\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0338-1684\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BRINGER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"RENARD, E\";i:1;s:18:\"GALTIER DEREURE, F\";i:2;s:10:\"JAFFIOL, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"Th\u00e9rapeutiques futures du diab\u00e8te. Symposium\";s:8:\"\u0000*\u0000title\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:6:\"Masson\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Diab\u00e8te et m\u00e9tabolisme (Paris)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Diab\u00e8te m\u00e9tab. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:4:\"2BIS\";s:8:\"\u0000*\u0000spage\";s:3:\"211\";s:8:\"\u0000*\u0000epage\";s:3:\"218\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0338-1684\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BRINGER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"RENARD, E\";i:1;s:18:\"GALTIER DEREURE, F\";i:2;s:10:\"JAFFIOL, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"Th\u00e9rapeutiques futures du diab\u00e8te. Symposium\";s:8:\"\u0000*\u0000title\";s:84:\"Perspectives dans le traitement du diab\u00e8te de type 2. Place de l'insulinotherapie ?\";s:8:\"\u0000*\u0000place\";s:5:\"Paris\";s:6:\"\u0000*\u0000pub\";s:6:\"Masson\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
